Visser TJ - Search Results

1

In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency.

Kersseboom S, Horn S, Visser WE, Chen J, Friesema EC, Vaurs-Barrière C, Peeters RP, Heuer H, Visser TJ. Kersseboom S, et al. Among authors: visser tj, visser we. Mol Endocrinol. 2014 Dec;28(12):1961-70. doi: 10.1210/me.2014-1135. Mol Endocrinol. 2014. PMID: 25389909 Free PMC article.

2

MCT8: from gene to disease and therapeutic approach.

Kersseboom S, Visser TJ. Kersseboom S, et al. Among authors: visser tj. Ann Endocrinol (Paris). 2011 Apr;72(2):77-81. doi: 10.1016/j.ando.2011.03.003. Epub 2011 Apr 20. Ann Endocrinol (Paris). 2011. PMID: 21511238

3

Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism.

Friesema EC, Kuiper GG, Jansen J, Visser TJ, Kester MH. Friesema EC, et al. Among authors: visser tj. Mol Endocrinol. 2006 Nov;20(11):2761-72. doi: 10.1210/me.2005-0256. Epub 2006 Aug 3. Mol Endocrinol. 2006. PMID: 16887882

4

Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8.

Friesema EC, Jansen J, Heuer H, Trajkovic M, Bauer K, Visser TJ. Friesema EC, et al. Among authors: visser tj. Nat Clin Pract Endocrinol Metab. 2006 Sep;2(9):512-23. doi: 10.1038/ncpendmet0262. Nat Clin Pract Endocrinol Metab. 2006. PMID: 16957765 Review.

5

Genotype-phenotype relationship in patients with mutations in thyroid hormone transporter MCT8.

Jansen J, Friesema EC, Kester MH, Schwartz CE, Visser TJ. Jansen J, et al. Among authors: visser tj. Endocrinology. 2008 May;149(5):2184-90. doi: 10.1210/en.2007-1475. Epub 2008 Jan 10. Endocrinology. 2008. PMID: 18187543 Free PMC article.

6

Thyroid hormone transport in and out of cells.

Visser WE, Friesema EC, Jansen J, Visser TJ. Visser WE, et al. Among authors: visser tj. Trends Endocrinol Metab. 2008 Mar;19(2):50-6. doi: 10.1016/j.tem.2007.11.003. Trends Endocrinol Metab. 2008. PMID: 18291666 Review.

7

Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10.

Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ. Friesema EC, et al. Among authors: visser tj, visser we. Mol Endocrinol. 2008 Jun;22(6):1357-69. doi: 10.1210/me.2007-0112. Epub 2008 Mar 12. Mol Endocrinol. 2008. PMID: 18337592 Free PMC article.

8

Thyroid hormone transport and metabolism by organic anion transporter 1C1 and consequences of genetic variation.

van der Deure WM, Hansen PS, Peeters RP, Kyvik KO, Friesema EC, Hegedüs L, Visser TJ. van der Deure WM, et al. Among authors: visser tj. Endocrinology. 2008 Oct;149(10):5307-14. doi: 10.1210/en.2008-0430. Epub 2008 Jun 19. Endocrinology. 2008. PMID: 18566113

9

Novel pathogenic mechanism suggested by ex vivo analysis of MCT8 (SLC16A2) mutations.

Visser WE, Jansen J, Friesema EC, Kester MH, Mancilla E, Lundgren J, van der Knaap MS, Lunsing RJ, Brouwer OF, Visser TJ. Visser WE, et al. Among authors: visser tj. Hum Mutat. 2009 Jan;30(1):29-38. doi: 10.1002/humu.20808. Hum Mutat. 2009. PMID: 18636565

10

Minireview: Pathophysiological importance of thyroid hormone transporters.

Heuer H, Visser TJ. Heuer H, et al. Among authors: visser tj. Endocrinology. 2009 Mar;150(3):1078-83. doi: 10.1210/en.2008-1518. Epub 2009 Jan 29. Endocrinology. 2009. PMID: 19179441 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

627 results

Search Page